CompletedNCT01015586
Lamotrigine for alcohol dependence in people with bipolarity
About this title
Treatment of Alcohol Dependence and Comorbid Bipolar Disorder
Read the official source — NCT01015586Medication studyAges 18–65United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
What did participation involve?
Depending on the group, the protocol specifies the study medication (lamotrigine) or a placebo (an inactive comparison treatment).
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 43
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01015586
- Official title
Show the full official title
A Double-Blind, Placebo-Controlled Trial of Lamotrigine In Individuals With Bipolar Disorder and Comorbid Alcohol Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Charleston
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine and Placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
